Double-Blind, Placebo-Controlled Trial of Topiramate (600 mg Daily) for the Treatment of Refractory Partial Epilepsy

• TASSIARI C. A.

  Institute of Clinical Neurology, Bellaria Hospital

• MICHELUCCI R

  Institute of Clinical Neurology, Bellaria Hospital

• CHAUVEL P

  CHU Pontchaillou/Service Neurologique, Rennes and Hospital St. Anne

• CHODKIEWICZ J

  CHU Pontchaillou/Service Neurologique, Rennes and Hospital St. Anne

• SHORVON S

  National Hospital

• HENRIKSEN O

  National Center for Epilepsy

• DAM M

  University Clinic of Neurology, Hvidovre Hospital

• REIFE R

  The R.W. Johnson Pharmaceutical Research Institute

• PLEDGER G

  The R.W. Johnson Pharmaceutical Research Institute

• KARIM R

  The R.W. Johnson Pharmaceutical Research Institute

収録刊行物

• Epilepsia : journal of the International League against Epilepsy

  Epilepsia : journal of the International League against Epilepsy 37 (8), 763-768, 1996-08-01

キーワード

• Topiramate
• Antiepileptic drug
• Partial epilepsy
• Secondarily generalized epilepsy

詳細情報

• CRID: 1570009749820850944
• NII論文ID: 10009401999
• NII書誌ID: AA00180597
• ISSN: 00139580
• 本文言語コード: en
• データソース種別:
  • CiNii Articles